The divy is great step forward but the one thing that analysts will be looking forward in light of falling birth rates and tough times in China is how things are performing this FY, especially considering the label changes and SM1 problems, this line from the outlook certainly is better than expected:
" China label IMF sales are broadly in line with plan taking into account supply constraints – production levels returned
to normal during 1Q25, and trade stock is returning to target levels ahead of Chinese New Year"
Ann: FY25 revenue guidance and dividend policy, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$8.09 |
Change
0.060(0.75%) |
Mkt cap ! $5.857B | |||
| Open | High | Low | Value | Volume |
| $8.05 | $8.11 | $8.02 | $12.16M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 985 | $8.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.10 | 1768 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| A2M (ASX) Chart |